Deep dive · NYSE: BMY
Bristol-Myers Squibb Company stock analysis
Everything behind the call on Bristol-Myers Squibb Company. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.
The five reads
Why the reads disagreeread this before the sections
2 factors lean up and 0 lean down and one side is clearly ahead. The net lands at +5 over 30d, a leaning reading on a dispersion of 0.00, which makes this a question of size rather than of direction.
Leans up · and why
earnings, quality / value vote up. 4 of 4 independent evidence families agree.
What it changes
Size, not direction. and the binding position cap is 3.9% — the tail cap is the one that binds.
Global tape
No overseas listings — BMY trades on its home exchange only.
The bottom linestart hereAs of 2026-09-18
Chart pattern
Between the averages
The 50-day sits above the 200-day
50-day $64.01 · -1.5%
200-day $58.02 · +8.7%
200-day $58.02 · +8.7%
Earnings
In 41 days
29 Oct 2026
beat 7–8 of the last 8
cohort P(beat) 80% · n=35,425
cohort P(beat) 80% · n=35,425
Valuation
9.7× forward
28th of its own five-year range
5yr median 18×
FCF yield 9.91%
FCF yield 9.91%
Dividend
4.00%
Forward annual yield at today's price
Risk flags
1 critical
5 checks run, 2 clear
beta 0.27 · vol 20% ann.
worst drawdown -13%
worst drawdown -13%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
In one paragraphwhat the company actually does143 chars
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
NYSE · USDGeneral Pharmaceutical
$63.06+0.22 · +0.35%AH · vol 36.83M
52-week range↑ 48% off low · ↓ 8.1% off high
$42.52now $63.06$68.64
Quote Sep 18, 2026 · time not on file
Tape 2026-09-17
Factors 2026-09-18
Tape 2026-09-17
Factors 2026-09-18
01Ratios · Jul 16, 2026
Survival & solvency
and 2 of 5 forensic checks clear.
↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Distance to default (Merton)
9.1σCOMFORTABLE
How many standard deviations of asset value sit between the company and its debt. Above 4σ is comfortable.
Balance sheetJul 16, 2026
1-year default probabilityEDF-CALIBRATED
0.100%
Calibrated against how often companies at this distance actually defaulted, rather than assuming a normal distribution.
Piotroski F-scoreCLEAR
F 9/9
Piotroski F-score 9 of 9. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Solvency and liquidity ratios
Current ratioshort-term assets against short-term bills1.26×healthy >2
Debt / equityborrowings against shareholder capital2.55
Leverage · long-term debt / equitythe borrowings that outlive a bad quarter0.50
Net debtborrowings in excess of cash on hand$36.93B
Your ownership stake
Share-count growth vs peersLOW DILUTION
45th pctile
Where this name's share-count growth ranks among peers. Lower is less dilutive.
Buyback yieldGROSS
0.00%
Repurchases as a share of market value, before new issuance is netted off.
Stock-based comp / revenueIN LINE
1.2%
Stock comp is the dilution pressure a buyback has to outrun. We read up to 5% of revenue as modest and above 12% as heavy — our own reading band, not a measured peer statistic.
Accounting forensicsSEC filings
Red-flag x-rayGRADE C
60 / 100
1 critical · 2 watch · 2 clear of 5 scored tests
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressWATCHZ 2.27Altman-Z in the Grey · fundamentals
Earnings manipulationCLEARM -2.68M-score in range · fundamentals
LeverageCRITICALLTD/E 2.32long-term debt 2.32× equity · fundamentals
Profitability qualityCLEARF 9/9Piotroski F-score 9 of 9 · fundamentals
Filing forensicsWATCH2 flags2 filing red flags on the latest 10-K · forensic
5 checks, 2 clear and 2 watch and 1 critical. The passes are shown because a score built from five checks means something different from one built from three.
02Refreshed · Sep 18, 2026GOOD · 67/100
Business quality
15% net margin, 38% return on equity, 0% revenue growth, and capital earning 18% against a 6% cost.
↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
Quality score
67 / 100GOOD
Profitability, growth and balance strength scored separately, then blended.
ProfitabilityRefreshed · Sep 18, 2026
Net marginOF EVERY SALES DOLLAR
14.6%
The share of revenue that survives every cost and becomes profit.
Gross marginPRICING POWER
71.1%
What is left of a sales dollar before overhead — the clearest read on pricing power.
Operating marginAFTER RUNNING COSTS
28.5%
What survives the cost of running the whole business.
Return on equityPER $1 OF EQUITY
38.2%
Annual return on each dollar of shareholder equity.
ROIC − WACC spreadCREATES VALUE
12.4pp
Earns 18% on invested capital that costs about 6%. A positive spread means every retained dollar compounds rather than leaks.
Asset growth vs peersIN LINE
32nd pctile
The balance sheet grew -3% on the year. Fast asset growth is usually a ramp; occasionally it is the start of an inventory problem.
Growth & relative strength
Trailing return by period
1 month-7.1%
3 months+16.4%
6 months+8.1%
Year to date+17.5%
1 year+36.2%
Revenue growth (YoY)SHRINKING
-0.2%
Revenue against the same period a year ago.
12-1 momentumEX LAST MONTH
+49.4%
Return over the last year excluding the most recent month — the standard momentum factor, which drops the short-term reversal.
Relative-strength rankTOP 20%
81 / 100
Where this name's 3-month return against the S&P 500 ranks across the market — a quarter's standing, not the year's.
Around earningsJul 30, 2026
P(beat next quarter)COHORT BASE RATE
80%
survivor-tilted universe (currently-listed names; large-cap-skewed coverage)
Beat rate · this nameBEAT 7–8 OF THE LAST 8
8 of 8
Its own record against consensus. 8 prints is a small sample, which is why the cohort rate above carries the probability.
Beat and still fellSHARE OF ALL PRINTS
42%
Of every report in the window, this share both beat consensus and closed lower on the day.
Typical earnings moveMEDIAN ABSOLUTE
±4.3%
Unsigned magnitudes from its own prints. Direction is not part of this read.
Reaction: beat vs missData unavailableThe beat-versus-miss reaction gap is not computed for this name — undetermined — needs ≥12 measured beats.
Consensus bias1.30× COHORT
Persistent
consensus runs low for this name — it routinely clears the bar
Dividends & income
Dividend yieldforward annual
4.00%
The cash return the payment alone provides at today's price.
Cash coveragefree cash flow
>2x
Whether the payment is funded out of the cash the business generates.
Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
Pattern reliability · platform-wide cohortSnapshot · Sep 18, 2026
Sideways
HorizonHigherMedianObservations
10d47%0.0%1,473,236
21d49%0.0%691,862
63d51%+0.2%218,831
slope +0.04 over 40 bars
Three black crows · leans bearish
HorizonHigherMedianObservations
10d51%+0.1%310,689
21d50%0.0%146,312
63d49%-0.4%46,362
three falling red bars
Double top · leans bearish
HorizonHigherMedianObservations
10d50%0.0%1,212,095
21d51%+0.1%570,206
63d52%+0.4%180,573
two peaks ≈ equal — reversal if neckline breaks
Triple top · leans bearish
HorizonHigherMedianObservations
10d50%0.0%971,828
21d52%+0.2%456,413
63d54%+0.5%144,062
three peaks ≈ equal
Head and shoulders · leans bearish
HorizonHigherMedianObservations
10d49%0.0%497,561
21d51%+0.1%234,322
63d51%+0.3%74,513
head above two ≈-equal shoulders — bearish reversal
Ascending triangle · leans bullish
HorizonHigherMedianObservations
10d50%0.0%643,427
21d51%+0.2%302,356
63d53%+0.5%95,587
flat resistance, rising support
0328TH OF ITS 5-YEAR RANGE
Price & timing
Price $63.06, 9.7× forward earnings, RSI 41.
↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Trend
Mixed1 OF 3 AVERAGES
50-day $64.01 · 200-day $58.02. Price above both is the structural definition of an uptrend.
The setup right now
Price · 504 sessions2024-09-13 → 2026-09-17
price50-day200-day
How to read this
Up 0.35% on the session.
Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.
Momentum (RSI-14)COOL
41
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
Typical day (ATR-14)±2.1%
$1.32
The average true range — how far this stock moves on an ordinary day. It sets the scale a stop has to clear.
MACDBELOW SIGNAL
-0.54
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Bollinger position10% OF RANGE
Lower band
Where price sits inside its own volatility band. The edges are where a move is stretched, not where it reverses.
20-day VWAPPRICE BELOW
$65.67
The volume-weighted average of the last month. Price above it means recent buyers are, on average, in profit.
Chandelier exitBROKEN
$64.67
A volatility-based trailing stop, set a few average ranges below the recent high.
29 Oct 2026 · in 41 daysNext earningsThe next scheduled catalyst. The forward guide usually moves the tape more than the printed number. Date as the vendor last stated it on 4 Aug; companies confirm about three weeks ahead, so it can still move.
2026-09-25 · in 7 daysConsumer SentimentA scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Direction oddsnext 12m
54 / 46cohort n=21,623
A lean, not a forecast. These are the cohort's odds — comparable names over the window — not this stock's own history.
Pullback riskoverstretch read
Low0.71× segment rate · n=10,214
Historically, large names in this tape state saw a ≥10% pullback within 63 trading days in 47% of cases (n=10,214).
Overstretchvs the 20-day mean
-1.7σ
How many standard deviations price sits from its 20-day mean. Beyond 2σ is genuinely stretched; inside it is ordinary.
Bottom zoneif it breaks down
$61 – $631 support
Where prior demand appeared: S1 at $62.12.
Slide scorefalling-knife check
3 / 100Neutral
A composite of consecutive down days, gap risk and volume expansion. Low means any decline is orderly.
Signal
The odds lean, the stretch qualifies it.
Historically, names tripping 0 validated red flags finished lower 12 months later in 46% of cases (n=21,623) — a survivor-biased floor, not a forecast.
Valuation
Earnings yield vs cashABOVE CASH
2.14pp
The earnings yield clears the risk-free rate, so the current return alone competes with cash.
Net cash per shareNET DEBT
$-12.64
Cash less every borrowing, per share. It is the part of the price that is not a claim on future profits.
Multiples
Forward P/Eearnings expected over the next 12 months9.7×5yr median 18×
Trailing P/Eearnings already reported14.0×28th of its 5yr range
Price / salesprice against revenue, before any of it becomes profit2.7×5yr median 2.5×
Price / bookprice against the accounting value of the assets7.0×
EV / EBITDAthe multiple an acquirer would pay10.9×
EV / free cash flowenterprise value against the cash the business throws off13.0×
FCF yieldfree cash flow per dollar of market value9.91%
1 of the 7 priced multiples above sits in the richer half of its band. Each priced multiple is read against this stock's own history where a five-year range is on file, so the question is whether today is dear for this name rather than for the market. The multiples are computed separately from the quote above and are not re-priced as it moves, so they can lag it.
Price horizon & timingSep 17, 2026
Entryzone of S1
$62.53Approach
Where the composer's entry sits, on its own stated basis.
TargetDaily pivot + vwap 50
$63.56$63–$64
A zone, not a price. It is where the composer expects supply, not a forecast.
Stop2× ATR below entry
$59.88risk $2.64/sh
The level that says the setup is wrong, on the basis named beside it.
Risk / rewardtarget vs stop
0.39:1flagged low
Less reward than risk at these levels. The composer publishes it rather than hiding it, because a sub-1 ratio is the argument against the trade.
Measure from a price$
To the 50-day
+1.5%
short-term trend line · $64.01
To the 200-day
-8.0%
primary trend line · $58.02
To the composer's target
+0.8%
Daily pivot + vwap 50 · set Sep 17, 2026 · $63.56
To the composer's stop
-5.0%
2× ATR below entry · set Sep 17, 2026 · $59.88
To the 52-week high
+8.8%
highest print of the past year · $68.64
To the 52-week low
-32.6%
lowest print of the past year · $42.52
A typical day (ATR)
$61.74 – $64.38
±$1.32 average true range
Type any price to re-measure every distance from it. Each row is a level this page already states somewhere else, so nothing here is a new number — and none of it is a recommendation to trade at that price.
Signal
Less reward than risk at this level.
Entry $62.53 · stop $59.88 · target $63.56, a 0.39:1 ratio. The composer flagged: fair-value reference, low reward to risk.
Gamma map
Data unavailableThis name has no listed options chain, so there is no dealer gamma to map. Regime, flip level, walls and the implied move all need a chain to exist.
Options tape
Data unavailableNo options chain is connected for this ticker. Max pain, the put/call ratio, the implied move and the open-interest ladder all need the chain feed.
0413F quarterly · Form 4 dailyNET SIGNAL +5
Ownership & flow
Institutions hold 85%, short interest is 2.16% of float.
↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Net signal
+5LEANING · 30d
2 bull / 0 bear factors. The points sum to the net beside the label; nothing here is weighted after the fact.
The QTick signalNightly
Earnings4 QUARTERS · TIMING
+3
latest EPS beat by 28%
Quality / valueTTM · CONTEXT
+2
strong Piotroski F-score (9/9)
Signal
2 bull / 0 bear factors
Independent factors scored and netted to +5 over 30d, a leaning reading. 2 of 9 factors carried a direction; the others scored zero and do not vote. The signal describes where the data leans, not what to do about it.
Cross-category readSep 18, 2026
Signal
4 of 4 families lean up.
Descriptive only — a decorrelated read of where the evidence agrees and conflicts, not a forecast and not advice. Patterns are condition lists, not outcome predictions, and are not yet validated to the proof bar. Dispersion of 0.00 means the disagreement is real but not a split decision.
Wall Street
Data unavailableNo sell-side firm publishes research on this name. There is no consensus rating, no price target and no estimate revisions to weigh — for a company this size that is the norm rather than a gap in our data.
Who owns it13F quarterly · Form 4 daily
Institutional ownershipINSTITUTIONALLY HELD
84.9%
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
Insider ownershipOFFICERS & DIRECTORS
0.1%
The share held by the people running the company.
Short interest (float)LIGHT
2.16%
Falling — shares short changed -15.8% over 30 days. There is no short base to squeeze here.
Free float100% OF SHARES
2.04B
Shares actually available to trade, excluding insider and restricted holdings.
Dollar volume (ADV)98th PCTILE
$699.50M/day
At this depth, position size is not a constraint for a retail account.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
The story · news & sentimentRolling window
Why it moved todayNONE
+0.35%
BMY was little changed +0.35% in after-hours trading — no notable catalyst, and the move itself was modest.
CongressSTOCK Act · 30–45d lag
Signal
Net buying.
4 of 6 disclosures are buys and 2 are sales. Lawmakers disclose on a 30–45 day legal lag, so this describes what was done weeks ago, not what is being done now.
0510 graded callsORDINARY VOLATILITY
Risk & track record
Beta 0.27, 20% annual volatility, a -13% worst drawdown, and 4 of 8 risk surfaces clear.
↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
Max drawdown
-12.5%WORST FALL
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
What it does to a portfolio5-year window
Beta (vs the market)LOW FIT
0.27
The market explains about 1.6% of its daily moves, so this beta says little about how it tracks the index — most of its movement is its own.
Annualized volatilityORDINARY
20%
How far it swings over a year, from its own realized returns.
Tactical phaseNIGHTLY READ
Neutral
Selling pressure62
Buying pressure2
Overheat0
State: neutral — No dominant short-horizon pressure in the tape.
What votes against
Data unavailableNo factor in the model currently votes against this name. That is a statement about the model's inputs today, not a claim that nothing could go wrong.
Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as growth, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Suggested position capmax defensible size
3.9%tail cap binds
max defensible size 3.9% - tail binds
Avoid score6-month distress
0.6%0.1× its cohort · most-traded mega-caps
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this most-traded mega-caps segment: 9.3%. This name reads 0.1× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
MedPosition size, not conviction, is the binding constrainthalf-Kelly 77.2% · tail cap 3.9% · category cap 90.1%. The tail cap binds, so 4.0% is the number (n=29,742). We show which one binds rather than the friendliest.Sizing
LowLottery-ticket behaviourIts best 21-day return sits at 2.4% against a 8.7% cohort 90th-percentile threshold — below the line where forward returns have historically turned negative.Behaviour
LowCash runwayNon-burner: catastrophe rate 6.1% (n=297414).Solvency
LowPost-earnings driftDrift odds at full strength (+2.24% / 63-day spread reference from measured post-earnings drift).Timing
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
4 of 8 surfaces clear.
8 surfaces checked, 4 clear. The binding constraint is position size — the tail cap is the one that binds. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.
Who should skip it
Skip it if any of these is you
You'd be buying into earnings
A report lands in 41 days.
Our track record10 resolved
Track recordBUILDING IN THE OPEN
31 logged
31 calls logged on this name, 10 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
Calls on BMYTHIS NAME
31
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 10.
0610-K disclosed linksGENERAL PHARMACEUTICAL
The wider context
5 mapped peers, 12 connections.
↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Rate sensitivity
-5.1% per +1ppINSUFFICIENT
This is the SECTOR prior, not a measurement of this name — the regression did not clear its own bar. The verdict beside it (neutral) comes from the prior too, so the two agree by construction rather than by evidence.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
LLYPeer$1,152.93+0.04%
JNJPeer$269.99-0.09%
ABBVPeer$263.96-0.02%
MRKCompetitor$146.87-0.19%
AZNPeer$166.08-0.04%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
Time machineHistory from 2023-06-01
Signal
Every backward window is positive.
That is the definition of a stock that has already worked, and it says nothing about the next window. What it does tell you is what a drawdown would be measured against.
Macro driversRolling window
Inflation (CPI) reactionn=39
1.04×
On these days it moves about 1.0× the market, regardless of company news.
Jobs report reactionn=40
0.90×
On these days it moves about 0.9× the market, regardless of company news.
Fed decision (FOMC) reactionn=39
1.46×
On these days it moves about 1.5× the market, regardless of company news.
Inflation (PCE) reactionn=39
1.08×
On these days it moves about 1.1× the market, regardless of company news.
Next macro catalystIN 7 DAYS
Consumer Sentiment
2026-09-25. A scheduled release that moves this stock independently of anything the company does.
Events · what moves this stockSep 18, 2026
Initial jobless claimsLittle effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day -0.1% · A week later 0.0% · Two weeks later +0.1% · Rose on 78 of 169 report days
Across the last 169 Initial jobless claims reports since Jun 8, 2023, BMY moved -0.1% on average on the day and was 0.1% higher two weeks later. The S&P 500 moved 0.0% on those days.
Core PCE (the Fed's gauge) is due in 12 days.
Core PCE (the Fed's gauge)Little effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day -0.1% · A week later +0.3% · Two weeks later -0.4% · Rose on 18 of 39 report days
Across the last 39 Core PCE (the Fed's gauge) reports since Jun 28, 2023, BMY moved -0.1% on average on the day and was 0.4% lower two weeks later. The S&P 500 moved +0.2% on those days.
FOMC decisionLittle effect either way
Healthcare demand does not depend on rates.
Typical for the Healthcare sector
On the day +0.2% · A week later -0.3% · Two weeks later -0.8% · Rose on 24 of 39 report days
Across the last 39 FOMC decision reports since Jul 1, 2023, BMY moved +0.2% on average on the day and was 0.8% lower two weeks later. The S&P 500 moved -0.1% on those days.
On the day -0.2% · A week later +0.3% · Two weeks later +0.6% · Rose on 19 of 39 report days
Across the last 39 Housing starts reports since Jun 20, 2023, BMY moved -0.2% on average on the day and was 0.6% higher two weeks later. The S&P 500 moved 0.0% on those days.
Industrial productionLittle effect either way
Healthcare does not track the business cycle.
Typical for the Healthcare sector
On the day +0.2% · A week later +0.9% · Two weeks later +1.0% · Rose on 22 of 39 report days
Across the last 39 Industrial production reports since Jun 15, 2023, BMY moved +0.2% on average on the day and was 1.0% higher two weeks later. The S&P 500 moved +0.1% on those days.
PCE inflation is due in 12 days.
PCE inflationLittle effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day -0.1% · A week later +0.3% · Two weeks later -0.4% · Rose on 18 of 39 report days
Across the last 39 PCE inflation reports since Jun 28, 2023, BMY moved -0.1% on average on the day and was 0.4% lower two weeks later. The S&P 500 moved +0.2% on those days.
Producer prices (PPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.1% · A week later 0.0% · Two weeks later +0.3% · Rose on 19 of 39 report days
Across the last 39 Producer prices (PPI) reports since Jun 12, 2023, BMY moved +0.1% on average on the day and was 0.3% higher two weeks later. The S&P 500 moved +0.3% on those days.
On the day +0.2% · A week later +0.9% · Two weeks later +1.0% · Rose on 22 of 39 report days
Across the last 39 Retail sales reports since Jun 15, 2023, BMY moved +0.2% on average on the day and was 1.0% higher two weeks later. The S&P 500 moved +0.1% on those days.
Customer momentum
Data unavailableThe supply-momentum read covered this name but produced no priced customers, so there is nothing to weight.
Connections12 links · 5 confirmed
Direct connections · 12 edges
CompanyRelationSessionProvenance
MRTX · Partnerpartnernot pricedRumored · manual
MRK · Competitorcompetitor-0.19%Confirmed · 10K
PFE · Partnerpartner+0.07%Rumored · manual
MRTX · Mergerpartnernot pricedRumored · manual
REPL · Partnerpartner+1.55%Rumored · manual
CLDX · Suppliersupplier-1.90%Confirmed · 10K
MCK · Suppliersupplier-0.56%Confirmed · 10K
COR · Suppliersupplier-0.20%Confirmed · 10K
CAH · Suppliersupplier-0.42%Confirmed · 10K
NKTR · Partnerpartner-1.84%Rumored · manual
ALMS · Competitorcompetitor-0.64%Rumored · manual
ONC · Partnerpartner-0.74%Rumored · manual
5 of 12 edges are named in a filing; the rest come from reporting we have not matched to one yet, and are labelled as such.
Suppliers, customers & competitors
Glossary · every term on this page
Survival
Altman Z
Bankruptcy-risk score. Above 3.0 is the safe band.
Piotroski F
Nine pass/fail health tests; 7 or more is strong.
Beneish M
Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.
Merton DTD
Standard deviations of asset value between the company and its debt.
EDF
Default frequency calibrated on what actually happened to similar names.
Price & tape
RSI-14
Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.
ATR
Average true range — the size of a typical day.
VWAP
20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.
Supertrend
A trend-following stop line. A close through it flips the read.
Chandelier
A trailing stop set a few average ranges below the recent high.
Options & flow
Gamma / GEX
Dealer hedging pressure. Negative gamma amplifies moves both ways.
Call / put wall
The strikes with the heaviest open interest; they act as ceiling and floor.
Max pain
The strike where most options expire worthless.
13F · Form 4
Institutional filings, 45 days after quarter end. Insider trades, within two days.
Scoring
Composite signal
Independent factors scored and netted into one number.
Hit-rate
Share of past calls that resolved in the direction stated.
Brier score
Calibration measure. Lower means stated probabilities track reality.
HHI
Concentration 0–10,000. Above 2,500 means one segment carries the company.
EVT
Fits the tail rather than assuming a bell curve, so bad days are not understated.